<DOC>
	<DOCNO>NCT00481325</DOCNO>
	<brief_summary>The purpose study learn safety efficacy pexacerfont outpatient diagnose Generalized Anxiety Disorder</brief_summary>
	<brief_title>Study Pexacerfont ( BMS-562086 ) Treatment Outpatients With Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Outpatient woman age 1865 meeting Diagnostic Statistical Manual Mental Disorders Manual , Fourth Edition , Text Revision ( DSMIV TR ) criterion Generalized Anxiety Disorder ( GAD ) , either moderate severe ( 300.02 ) Males Patients report history inadequate response three adequate trial selective Serotonin reuptake inhibitor ( SSRIs ) GAD within last three year</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>